FORFARMERS NV (FFARM.AS) Fundamental Analysis & Valuation

AMS:FFARM • NL0011832811

Current stock price

6.28 EUR
-0.07 (-1.1%)
Last:

This FFARM.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. FFARM.AS Profitability Analysis

1.1 Basic Checks

  • In the past year FFARM was profitable.
  • FFARM had a positive operating cash flow in the past year.
  • FFARM had positive earnings in 4 of the past 5 years.
  • FFARM had a positive operating cash flow in each of the past 5 years.
FFARM.AS Yearly Net Income VS EBIT VS OCF VS FCFFFARM.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • FFARM's Return On Assets of 4.49% is fine compared to the rest of the industry. FFARM outperforms 63.93% of its industry peers.
  • FFARM has a better Return On Equity (13.95%) than 75.41% of its industry peers.
  • FFARM's Return On Invested Capital of 11.56% is amongst the best of the industry. FFARM outperforms 91.80% of its industry peers.
  • FFARM had an Average Return On Invested Capital over the past 3 years of 6.69%. This is in line with the industry average of 7.00%.
  • The 3 year average ROIC (6.69%) for FFARM is below the current ROIC(11.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.49%
ROE 13.95%
ROIC 11.56%
ROA(3y)2.57%
ROA(5y)2.15%
ROE(3y)7.73%
ROE(5y)6.38%
ROIC(3y)6.69%
ROIC(5y)5.46%
FFARM.AS Yearly ROA, ROE, ROICFFARM.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

  • The Profit Margin of FFARM (1.58%) is worse than 60.66% of its industry peers.
  • FFARM's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 2.78%, FFARM is doing worse than 67.21% of the companies in the same industry.
  • FFARM's Operating Margin has improved in the last couple of years.
  • FFARM has a Gross Margin of 19.38%. This is in the lower half of the industry: FFARM underperforms 77.05% of its industry peers.
  • In the last couple of years the Gross Margin of FFARM has remained more or less at the same level.
Industry RankSector Rank
OM 2.78%
PM (TTM) 1.58%
GM 19.38%
OM growth 3Y45.68%
OM growth 5Y2.18%
PM growth 3Y42.84%
PM growth 5Y21.33%
GM growth 3Y9.1%
GM growth 5Y1.03%
FFARM.AS Yearly Profit, Operating, Gross MarginsFFARM.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

7

2. FFARM.AS Health Analysis

2.1 Basic Checks

  • FFARM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • FFARM has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for FFARM has been reduced compared to 5 years ago.
  • Compared to 1 year ago, FFARM has an improved debt to assets ratio.
FFARM.AS Yearly Shares OutstandingFFARM.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
FFARM.AS Yearly Total Debt VS Total AssetsFFARM.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • FFARM has an Altman-Z score of 3.88. This indicates that FFARM is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 3.88, FFARM belongs to the best of the industry, outperforming 86.89% of the companies in the same industry.
  • The Debt to FCF ratio of FFARM is 1.80, which is an excellent value as it means it would take FFARM, only 1.80 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.80, FFARM belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
  • A Debt/Equity ratio of 0.20 indicates that FFARM is not too dependend on debt financing.
  • FFARM has a better Debt to Equity ratio (0.20) than 81.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.8
Altman-Z 3.88
ROIC/WACC1.79
WACC6.46%
FFARM.AS Yearly LT Debt VS Equity VS FCFFFARM.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 1.09 indicates that FFARM should not have too much problems paying its short term obligations.
  • FFARM has a worse Current ratio (1.09) than 65.57% of its industry peers.
  • FFARM has a Quick Ratio of 1.09. This is a bad value and indicates that FFARM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FFARM has a Quick ratio of 0.79. This is comparable to the rest of the industry: FFARM outperforms 47.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.79
FFARM.AS Yearly Current Assets VS Current LiabilitesFFARM.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

5

3. FFARM.AS Growth Analysis

3.1 Past

  • FFARM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 70.05%, which is quite impressive.
  • FFARM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.68% yearly.
  • FFARM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.84%.
  • FFARM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.04% yearly.
EPS 1Y (TTM)70.05%
EPS 3Y41.1%
EPS 5Y30.68%
EPS Q2Q%4.2%
Revenue 1Y (TTM)14.84%
Revenue growth 3Y-1.66%
Revenue growth 5Y6.04%
Sales Q2Q%13.74%

3.2 Future

  • Based on estimates for the next years, FFARM will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.28% on average per year.
  • The Revenue is expected to grow by 0.18% on average over the next years.
EPS Next Y8.47%
EPS Next 2Y9.7%
EPS Next 3Y9.28%
EPS Next 5YN/A
Revenue Next Year-1.98%
Revenue Next 2Y1.81%
Revenue Next 3Y0.18%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FFARM.AS Yearly Revenue VS EstimatesFFARM.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
FFARM.AS Yearly EPS VS EstimatesFFARM.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8 1

8

4. FFARM.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.21, the valuation of FFARM can be described as very reasonable.
  • Based on the Price/Earnings ratio, FFARM is valued a bit cheaper than 78.69% of the companies in the same industry.
  • FFARM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.89.
  • A Price/Forward Earnings ratio of 9.53 indicates a reasonable valuation of FFARM.
  • 80.33% of the companies in the same industry are more expensive than FFARM, based on the Price/Forward Earnings ratio.
  • FFARM's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 11.21
Fwd PE 9.53
FFARM.AS Price Earnings VS Forward Price EarningsFFARM.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 91.80% of the companies in the same industry are more expensive than FFARM, based on the Enterprise Value to EBITDA ratio.
  • FFARM's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FFARM is cheaper than 96.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.8
EV/EBITDA 4.15
FFARM.AS Per share dataFFARM.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • FFARM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.32
PEG (5Y)0.37
EPS Next 2Y9.7%
EPS Next 3Y9.28%

6

5. FFARM.AS Dividend Analysis

5.1 Amount

  • FFARM has a Yearly Dividend Yield of 4.65%, which is a nice return.
  • Compared to an average industry Dividend Yield of 3.59, FFARM pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, FFARM pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.65%

5.2 History

  • The dividend of FFARM decreases each year by -37.30%.
Dividend Growth(5Y)-37.3%
Div Incr Years1
Div Non Decr Years1
FFARM.AS Yearly Dividends per shareFFARM.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

  • FFARM pays out 4.61% of its income as dividend. This is a sustainable payout ratio.
DP4.61%
EPS Next 2Y9.7%
EPS Next 3Y9.28%
FFARM.AS Yearly Income VS Free CF VS DividendFFARM.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M
FFARM.AS Dividend Payout.FFARM.AS Dividend Payout, showing the Payout Ratio.FFARM.AS Dividend Payout.PayoutRetained Earnings

FFARM.AS Fundamentals: All Metrics, Ratios and Statistics

FORFARMERS NV

AMS:FFARM (3/30/2026, 11:34:05 AM)

6.28

-0.07 (-1.1%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-19
Earnings (Next)05-07
Inst Owners3.67%
Inst Owner ChangeN/A
Ins Owners5.48%
Ins Owner ChangeN/A
Market Cap560.68M
Revenue(TTM)3.15B
Net Income(TTM)49.90M
Analysts86
Price Target7.91 (25.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.65%
Yearly Dividend0.03
Dividend Growth(5Y)-37.3%
DP4.61%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)30.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)14.29%
EPS NY rev (3m)14.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)0.22%
Valuation
Industry RankSector Rank
PE 11.21
Fwd PE 9.53
P/S 0.18
P/FCF 5.8
P/OCF 3.78
P/B 1.57
P/tB 2.3
EV/EBITDA 4.15
EPS(TTM)0.56
EY8.92%
EPS(NY)0.66
Fwd EY10.5%
FCF(TTM)1.08
FCFY17.23%
OCF(TTM)1.66
OCFY26.45%
SpS35.32
BVpS4.01
TBVpS2.73
PEG (NY)1.32
PEG (5Y)0.37
Graham Number7.11
Profitability
Industry RankSector Rank
ROA 4.49%
ROE 13.95%
ROCE 14.56%
ROIC 11.56%
ROICexc 14.11%
ROICexgc 18.32%
OM 2.78%
PM (TTM) 1.58%
GM 19.38%
FCFM 3.06%
ROA(3y)2.57%
ROA(5y)2.15%
ROE(3y)7.73%
ROE(5y)6.38%
ROIC(3y)6.69%
ROIC(5y)5.46%
ROICexc(3y)7.78%
ROICexc(5y)6.32%
ROICexgc(3y)10.07%
ROICexgc(5y)8.15%
ROCE(3y)8.56%
ROCE(5y)7.09%
ROICexgc growth 3Y43.98%
ROICexgc growth 5Y2.65%
ROICexc growth 3Y42.97%
ROICexc growth 5Y3.15%
OM growth 3Y45.68%
OM growth 5Y2.18%
PM growth 3Y42.84%
PM growth 5Y21.33%
GM growth 3Y9.1%
GM growth 5Y1.03%
F-Score7
Asset Turnover2.84
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.8
Debt/EBITDA 0.48
Cap/Depr 81.42%
Cap/Sales 1.64%
Interest Coverage 13.29
Cash Conversion 98.08%
Profit Quality 193.59%
Current Ratio 1.09
Quick Ratio 0.79
Altman-Z 3.88
F-Score7
WACC6.46%
ROIC/WACC1.79
Cap/Depr(3y)71.4%
Cap/Depr(5y)75.64%
Cap/Sales(3y)1.27%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.05%
EPS 3Y41.1%
EPS 5Y30.68%
EPS Q2Q%4.2%
EPS Next Y8.47%
EPS Next 2Y9.7%
EPS Next 3Y9.28%
EPS Next 5YN/A
Revenue 1Y (TTM)14.84%
Revenue growth 3Y-1.66%
Revenue growth 5Y6.04%
Sales Q2Q%13.74%
Revenue Next Year-1.98%
Revenue Next 2Y1.81%
Revenue Next 3Y0.18%
Revenue Next 5YN/A
EBIT growth 1Y58.3%
EBIT growth 3Y43.27%
EBIT growth 5Y8.35%
EBIT Next Year80.65%
EBIT Next 3Y25.38%
EBIT Next 5YN/A
FCF growth 1Y130%
FCF growth 3Y95.64%
FCF growth 5Y9.14%
OCF growth 1Y111.25%
OCF growth 3Y45.44%
OCF growth 5Y8.61%

FORFARMERS NV / FFARM.AS Fundamental Analysis FAQ

What is the fundamental rating for FFARM stock?

ChartMill assigns a fundamental rating of 6 / 10 to FFARM.AS.


Can you provide the valuation status for FORFARMERS NV?

ChartMill assigns a valuation rating of 8 / 10 to FORFARMERS NV (FFARM.AS). This can be considered as Undervalued.


What is the profitability of FFARM stock?

FORFARMERS NV (FFARM.AS) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for FFARM stock?

The Price/Earnings (PE) ratio for FORFARMERS NV (FFARM.AS) is 11.21 and the Price/Book (PB) ratio is 1.57.


Can you provide the dividend sustainability for FFARM stock?

The dividend rating of FORFARMERS NV (FFARM.AS) is 7 / 10 and the dividend payout ratio is 4.61%.